2005
DOI: 10.1007/0-387-24361-5_15
|View full text |Cite
|
Sign up to set email alerts
|

Novel Cytokines in the Treatment of Malignancies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 80 publications
0
1
0
Order By: Relevance
“…RNA was converted to complementary DNA by reverse transcription and used as a template for RT-PCR using FR-α (forward primer, TGGGTGGCTGTAGTAGGGGAG; reverse primer, CAGGGGCACGTTCAGTACC) and FR-β primers (forward primer, ACCAATGCAGTCC-CTGGAAGAAGA; reverse primer, AGCTGGGCACTTGTTAACTCCTGA) [32]. The PCR conditions consisted of 95°C for 30s followed by 30 cycles of 95°C for 30s, 58°C for 30s, and 72°C for 40s.…”
Section: Methodsmentioning
confidence: 99%
“…RNA was converted to complementary DNA by reverse transcription and used as a template for RT-PCR using FR-α (forward primer, TGGGTGGCTGTAGTAGGGGAG; reverse primer, CAGGGGCACGTTCAGTACC) and FR-β primers (forward primer, ACCAATGCAGTCC-CTGGAAGAAGA; reverse primer, AGCTGGGCACTTGTTAACTCCTGA) [32]. The PCR conditions consisted of 95°C for 30s followed by 30 cycles of 95°C for 30s, 58°C for 30s, and 72°C for 40s.…”
Section: Methodsmentioning
confidence: 99%